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Background. Ether phospholipids are abundant membrane constituents present in electrically active tissues (e.g., heart and
the brain) that play important roles in cellular function. Alterations of ether phospholipid molecular species contents are
associated with a number of genetic disorders and human diseases. Methodology/Principal Findings. Herein, the power of
shotgun lipidomics, in combination with high mass accuracy/high resolution mass spectrometry, was explored to identify a
paired rule for the presence of isomeric ether phospholipid molecular species in cellular lipidomes. The rule predicts that if an
ether phospholipid A9-B is present in a lipidome, its isomeric counterpart B9-A is also present (where the 9 represents an ether
linkage). The biochemical basis of this rule results from the fact that the enzymes which participate in either the sequential
oxidation of aliphatic alcohols to fatty acids, or the reduction of long chain fatty acids to aliphatic alcohols (metabolic
precursors of ether lipid synthesis), are not entirely selective with respect to acyl chain length or degree of unsaturation.
Moreover, the enzymatic selectivity for the incorporation of different aliphatic chains into the obligatory precursor of ether
lipids (i.e., 1-O-alkyl-glycero-3-phosphate) is also limited. Conclusions/Significance. This intrinsic amplification of the
number of lipid molecular species present in biological membranes predicted by this rule and demonstrated in this study
greatly expands the number of ether lipid molecular species present in cellular lipidomes. Application of this rule to mass
spectrometric analyses provides predictive clues to the presence of specific molecular species and greatly expands the number
of identifiable and quantifiable ether lipid species present in biological samples. Through appropriate alterations in the
database, use of the paired rule increases the number of identifiable metabolites in metabolic networks, thereby facilitating
identification of biomarkers presaging disease states.
Citation: Yang K, Zhao Z, Gross RW, Han X (2007) Shotgun Lipidomics Identifies a Paired Rule for the Presence of Isomeric Ether Phospholipid
Molecular Species. PLoS ONE 2(12): e1368. doi:10.1371/journal.pone.0001368
INTRODUCTION
Plasmalogens are a unique subclass of phospholipids, containing
an O-alk-19-enyl aliphatic chain at the sn-1 position of glycerol.
Plasmalogen molecular species are predominantly present in
choline and ethanolamine glycerophospholipids [1,2]. Plasmalo-
gens exist, to varying degrees, essentially in all subcellular
membranes and organelles from a variety of cells from virtually
all mammalian tissues examined [1]. Previous studies have
underscored the enrichment of plasmalogens in electrically active
tissues such as heart and the brain [1,3–5].
Altered plasmalogen content has been linked to a number of
genetic disorders including Zellweger syndrome and Refsum
disease [6] and neurodegenerative disorders (e.g., Alzheimer’s
disease) as well as psychiatric disorders (e.g., bipolarism) [4,7]. The
content and composition of plasmalogen molecular species are
uniquely tailored to the specific functions of a particular cell type.
For example, both gray and white matters of the brain contain
abundant amounts of ethanolamine plasmalogen (i.e., plasmeny-
lethanolamine, pPtdEtn) molecular species. The majority (55–
60 mol%) of pPtdEtn molecular species in gray matter contain
four or more double bonds in fatty acids esterified at the sn-2
position whereas 18:1-18:1 pPtdEtn represents over 85 mol% of
the total pPtdEtn in white matter [4]. Myelin-enriched white
matter requires plasmalogen (instead of its diacyl counterpart) to
provide a sufficiently compact membrane structure for the efficient
function of the axonal sheath [8]. Thus, pPtdEtn molecular species
in white matter contain less unsaturated acyl constituents at the sn-
2 position to enhance membrane packing. In contrast, pPtdEtn
molecular species in gray matter contain abundant polyunsatu-
rated acyl chains (e.g., 20:4 and 22:6 FA) which can efficiently
promote membrane fusion and can serve as a reservoir of essential
lipid signaling molecules [9–11]. Notably, these polyunsaturated
pPtdEtn molecular species facilitate membrane fusion between
synaptic vesicles and the neuronal plasma membrane, thereby
allowing neurotransmitter release at synaptic terminals. Consid-
ering the importance of plasmalogen molecular species to cellular
function, detailed investigations of ether lipid biosynthesis,
remodeling, trafficking, and catabolism will depend heavily on
the advances in lipidomics that facilitate increased identification,
quantitation, and kinetics of the numerous plasmalogens molec-
ular species present in biological samples.
Historically, plasmalogen molecular species have been separat-
ed by straight phase or cation exchange high performance liquid
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analyzed by reversed phase HPLC [12]. In many cases, enzymatic
hydrolysis of the head group and/or derivatization has been
employed [2,13]. The identities of the fractionated peaks were
identified by gas chromatography (GC) or GC/mass spectrometric
(MS) analyses after derivatization (e.g., acid methanolysis) [3,12].
Fast atom bombardment (FAB) mass spectrometry has provided
important information about the content of plasmalogen molec-
ular species in heart subcellular fractions [3,12]. Recently,
increases in the sensitivity of detection of ions, largely due to the
sensitivity inherent in electrospray ionization (ESI)/MS, have
greatly improved the identification efficiency of low abundance
plasmalogen molecular species from complex lipid mixtures [14–
17]. However, detailed analysis of low abundance plasmalogen
molecular species is still complicated by their lability and the
difficulties inherent in the identification of extremely low
abundance ions in general. This is particularly prominent in the
case of plasmalogens that are potentially isomeric with O-alkyl (i.e.,
plasmanyl) phospholipid molecular species.
During our global analyses of a variety of cellular lipid extracts
using the shotgun lipidomics technology we have recently
developed [18,19], an intriguing phenomenon has been observed.
Specifically, we observed a molecular ion peak corresponding to a
plasmalogen molecular species in which a low abundance fatty
acyl carboxylate fragment A co-exists with an abundant fatty acyl
carboxylate fragment B at the identical m/z during precursor ion
scanning or product ion analysis. This plasmalogen species
contained a fatty acyl moiety B and an O-alk-19-enyl aliphatic
chain A9 which possessed an identical number of carbon atoms
and degree of unsaturation (not including the O-vinyl bond) as that
of carboxylate fragment A shown in Figure 1. Therefore, we
hypothesized that an isomeric plasmalogen molecular species B9-A
is also likely present albeit at a much lower abundance, in addition
to the readily observable abundant plasmalogen molecular species
A9-B (defined hereafter as ‘‘a paired rule’’) (Figure 1). In this study,
we exploited recent advances in high mass accuracy/high
resolution mass spectrometry to examine this hypothesis with a
variety of cellular lipid extracts in tissue samples from multiple
organs (e.g., heart, brain, intestine, liver, kidney, and dorsal root
ganglia) obtained from multiple animal species (e.g., rat, mouse,
rabbit, and bovine). The results demonstrate that this ‘‘paired
rule’’ is present for very low abundance plasmalogen molecular
species as well as plasmanyl glycerophospholipid molecular species
in all cells and species examined. Thus, through scanning all
potentially naturally occurring fatty acyl carboxylates in a two-
dimensional MS approach [19,20], use of this rule can increase
penetrance into the lipidome containing ether phospholipids.
MATERIALS AND METHODS
Materials
Synthetic 18:0-20:4 plasmenylethanolamine (pPtdEtn) and other
synthetic phospholipids used in the study were purchased from
Avanti Polar Lipids, Inc. (Alabaster, AL, USA). Solvents for
sample preparation and for MS analysis were obtained from
Burdick and Jackson (Burdick and Jackson, Muskegon, MI, USA).
All other chemical reagents were at least analytical grade or the
best grade available and obtained from either Thermo Fisher
Scientific (Pittsburgh, PA, USA) or Sigma-Aldrich Chemical
Company (St. Louis, MO, USA) or as indicated.
Preparation of lipid extracts from biological samples
Fresh bovine heart was obtained from a local slaughter house. Male
mice (C57BL/6, 4 months of age) or male Sprague-Dawley rats (2
months of age) were purchased from The Jackson Laboratory (Bar
Harbor, ME, USA) or Charles River Laboratories, Inc. (Wilming-
ton, MA, USA), respectively. Male New Zealand white rabbits (2–
3 lbs. body weight) were purchased from Myrtles Rabbitry, Inc.
(Thompson Station, TN, USA). Animals were sacrificed by
asphyxiation with carbon dioxide. Brain, heart, kidney, liver,
intestine, dorsal root ganglial tissues were dissected, perfused with
phosphate-buffered saline to remove blood, blotted with Kim-wipes
to remove excess buffer, and immediately freeze-clamped at the
temperature of liquid nitrogen. Wafers were pulverized into a fine
powderwithastainlesssteelmortarandpestle.Eachindividualtissue
sample (approximately 10 mg of fine powder) was weighed into a
disposable glass test tube. A mixture of necessary internal standards
were added to each individual homogenate prior to extraction by
using a modified Bligh and Dyer procedure [21] as described
previously[22].Eachlipidextractwasreconstitutedwithavolumeof
500 ml chloroform/methanol (1:1, v/v) per mg protein. The lipid
extracts were finally flushed with nitrogen, capped, and stored at
220uC for ESI/MS analyses (typically within one week). PtdEtn
from bovine heart was isolated by using HPLC of lipid extracts
employing a silica based cation-exchange column as previously
described [23]. Each lipid solution was diluted appropriately prior to
infusion and lipid analysis to prevent aggregation and minimize the
residual salt content.
Instrumentation and mass spectrometry
Lipid extracts were diluted in chloroform/methanol/isopropanol
(1:2:4, v/v/v) to a final concentration of 10–50 pmol total lipids/
ml followed by addition of a small amount of LiOH prior to direct
infusion. Mass spectrometric analysis was performed on an LTQ-
Orbitrap mass spectrometer (Thermo Fisher Scientific, Inc., San
Jose, CA, USA) equipped with an automated nanospray apparatus
(i.e., Nanomate HD, Advion Bioscience Ltd., Ithaca, NY, USA).
An ionization voltage of 1.1 kV and a gas pressure of 0.3 psi on
the Nanomate apparatus were employed in the analyses. The
Nanomate was controlled by Chipsoft 6.3.2 software. The LTQ-
Orbitrap mass spectrometer was operated in the negative ion
mode under a resolution setting of 60,000. The temperature of the
ion transfer tube in the ion source was set at 160uC. Product-ion
analyses were conducted using a peak width setting of 1 Th by
selection of the molecular ion in the linear ion trap, a normalized
collision energy in the C-trap of 55%, and a gas pressure of 1 mT
prior to analyses of the resultant product ions in the Orbitrap.
Mass spectra in both full scan and MS/MS scan modes were
acquired under the control of Xcalibur software.
Shotgun lipidomics analyses of PtdEtn molecular species of all
lipid extracts were also performed on a QqQ mass spectrometer
(Thermo Fisher TSQ Quantum Ultra Plus, San Jose, CA, USA)
equipped with an electrospray ion source as previously described
[20]. All ESI/MS analyses of lipids were conducted by direct
infusion employing a Harvard syringe pump at a flow rate of 4 ml/
min. Typically, a 1-min period of signal averaging was employed
for each mass spectrum and a 2-min period of signal averaging was
Figure 1. The structures of the paired isomers of plasmenylethano-
lamine molecular species.
doi:10.1371/journal.pone.0001368.g001
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Th at half peak width was used for both MS and tandem MS
analyses performed by the QqQ mass spectrometer. For tandem
mass spectrometry, a collision gas pressure was set at 1.0 mT, but
the collision energy varied with the classes of lipids analyzed as
described previously [18].
Miscellaneous
Protein concentration was determined with a bicinchroninic acid
protein assay kit (Pierce, Rockford, IL, USA) using bovine serum
albumin as a standard. Data from biological samples were
normalized to the protein content and all data are presented as
the mean6SD of n$4 for lipid analyses.
RESULTS
High mass accuracy and CID fragmentation analyses
reveal the presence of paired, isomeric
plasmenylethanolamine molecular species in
isolated bovine heart PtdEtn
PtdEtn molecular species were readily analyzed as deprotonated
molecular ions by ESI/MS in the negative-ion mode (Figure 2) as
previously described [18,24]. Abundant pPtdEtn molecular species
were present in isolated bovine heart PtdEtn as previously
described [25]. However, isobaric ions to these pPtdEtn molecular
species (corresponding to phosphatidylethanolamine (dPtdEtn)
molecular species) were also present and were readily resolved
using the high resolution present in an Orbitrap analyzer (Inset B
of Figure 2). Tandem MS analysis of each individual isobaric ion
peak corresponding to a representative deprotonated pPtdEtn
molecular species always demonstrated the presence of multiple
pPtdEtn isomers along with isomeric plasmanylethanolamine
(aPtdEtn) and isobaric dPtdEtn molecular species (Figures 2 and
3 and Table 1). For example, product-ion MS analysis of an
isobaric ion at m/z 772.5 (0.26% relative abundance to the base
peak at m/z 766.54, Figure 2, inset A of Figure 2, and Table 1)
from bovine heart PtdEtn in the negative-ion mode was performed
with a mass selection window of 1 Th using an LTQ-Orbitrap
mass spectrometer after collision-induced activation (CID). The
CID analysis of this isobaric ion demonstrated multiple abundant
fragment ions in the carboxylate region in an order of abundance
at m/z 281.25 (i.e., 18:1 FA), m/z 329.25 (i.e., 22:5 FA), m/z
279.23 (i.e., 18:2 FA), m/z 327.23 (i.e., 22:6 FA), m/z 311.29 (i.e.,
20:0 FA), m/z 309.28 (i.e., 20:1 FA), m/z 283.26 (i.e., 18:0 FA),
and m/z 303.23 (i.e., 20:4 FA) (inset of Figure 3A). It is noteworthy
that the ions at m/z 283.24 and 285.26 (inset of Figure 3A)
correspond to aliphatic anions resulting from the loss of a CO2
molecule from 22:6 FA (m/z 327.23) and 22:5 FA (m/z 329.25),
respectively. Loss of a CO2 molecule from polyunsaturated fatty
acyl carboxylates (e.g., 20:5, 22:5, and 22:6 FA) is common as
previously demonstrated [5,17]. Loss of a CO2 molecule from
arachidonate (20:4 FA) can also be detected, but is relatively less
rapid in comparison to other aforementioned polyunsaturated
fatty acids. The most common fragmentation pathway likely
results from the resonance stabilized anion conjugated to olefinic p
clouds. Since the content of the selected molecular ion at m/z
772.5 was markedly decreased in the lipid mixture following
treatment with acid vapor as described previously [5], this ion
largely represented a deprotonated pPtdEtn or isomeric pPtdEtn
mixtures. Based on the identified FA carboxylates through
accurate mass analyses, the accurate mass of the precursor ion
(i.e., m/z 772.53), and the known information about the ion (i.e.,
predominantly deprotonated pPtdEtn), gave rise to the conclusion
that the ion at m/z 772.53 is comprised of at least four pPtdEtn
isomers, including 18:2-22:5, 18:1-22:6, 22:6-18:1, and 22:5-18:2
pPtdEtn molecular species in the order of relative abundance. The
molar ratio of these isomers was approximately 6:5:5:4 from the
Figure 2. Representative negative-ion ESI/MS analyses of bovine heart ethanolamine glycerophospholipid molecular species. Bovine heart lipids
were extracted by a modified Bligh and Dyer procedure [21] and the PtdEtn fraction was separated by using HPLC with a cation-exchange column as
previously described [23]. Analyses of PtdEtn molecular species were performed in the negative-ion mode by using an LTQ-Orbitrap mass
spectrometer equipped with a Nanomate device as described under ‘‘MATERIALS AND METHODS’’.
doi:10.1371/journal.pone.0001368.g002
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PLoS ONE | www.plosone.org 7 December 2007 | Issue 12 | e1368intensities of FA carboxylates after considering the differential
fragmentation kinetics of different molecular species as previously
described [24]. The relative ratios of each individual molecular
species are listed in parentheses underneath the corresponding
molecular species in Table 1.
The presence of modestly abundant fragment ions derived from
lysoPtdEtn further supported the identification of these pPtdEtn
molecular species. However, previously identified O-alkenyl ions
resulting from the O-alk-19-enyl chain of pPtdEtn [25] were either
present at very low intensities or could not be detected under the
experimental conditions employed that were largely dependent on
the abundance of the corresponding molecular ions. These results
indicate that pPtdEtn isomers of the examined ion in the negative-
ion ESI/MS analysis of bovine heart PtdEtn occur in pairs (i.e.,
18:1-22:6/22:6-18:1 and 18:2-22:5/22:5-18:2 pPtdEtn). Further-
more, 20:4-20:4 aPtdEtn was also identified from the presence of a
very low abundance fragment ion at m/z 303.23 (i.e., 20:4 FA) in
the CID fragment analyses of the selected isobaric ion, which
along with the presence of 20:3-20:4 pPtdEtn is further described
below in detail. Accurate mass analyses of the fragments
corresponding to carboxylates (i.e., m/z 281.25 (i.e., 18:1 FA),
m/z 311.29 (i.e., 20:0 FA), m/z 309.28 (i.e., 20:1 FA), m/z 283.26
(i.e., 18:0 FA)) identified the presence of 18:1-20:0/20:0-18:1 and
18:0-20:1/20:1-18:0 dPtdEtn from the selected isobaric ion at m/z
772.59 (Table 1).
Next, we determined if pPtdEtn molecular species pairing was
present in other pPtdEtn molecular ions having more complicated
isomeric patterns. For example, the CID mass spectrum of the
acid-labile pPtdEtn ion at m/z 774.5 from bovine heart PtdEtn in
the negative-ion mode (Figure 3B, 2.60% relative abundance to
the base peak at m/z 766.54 of the mass spectrum (Figure 2))
displays multiple fragment ions in the carboxylate region. These
fragments included ions at m/z 329.25 (i.e., 22:5 FA), m/z 285.26
(i.e., loss of a CO2 from 22:5 FA), m/z 327.23 (i.e., 22:6 FA), m/z
283.24 (i.e., loss of a CO2 from 22:6 FA), m/z 279.23 (i.e., 18:2
FA), m/z 283.26 (i.e., 18:0 FA), m/z 311.29 (i.e., 20:0 FA), m/z
331.26 (i.e., 22:4 FA), m/z 303.23 (i.e., 20:4 FA), m/z 281.23 (i.e.,
18:1 FA), m/z 307.26 (i.e., 20:2 FA), m/z 265.25 (i.e.,
corresponding to 9-octadecen-19-enolate), and m/z 267.23 (i.e.,
17:1 FA) in order of abundance (insets of Figure 3B). Obviously,
four pairs of pPtdEtn molecular species including 18:1-22:5/22:5-
18:1, 18:0-22:6/22:6-18:0, 22:4-18:2/18:2-22:4, 20:2-20:4/20:4-
20:2 pPtdEtn were identified from the molecular ion at m/z
774.54 through accurate mass analyses of the obtained carboxylate
fragments. The presence of 9-octadecen-19-enolate results from
the fact that pPtdEtn molecular species containing 18:1 vinyl ether
is the most abundant molecular ion present in comparison to
others. Again, the presence of low abundance isomeric 18:1-22:6/
22:6-18:1 and 18:2-22:5/22:5-18:2 aPtdEtn within the molecular
ion of m/z 774.54 (Table 1) were also identified and are described
Figure 3. Product ion analyses of individual molecular species present in isolated bovine heart ethanolamine glycerophospholipids. Product ion
ESI/MS analyses of PtdEtn molecular species in isolated bovine heart ethanolamine glycerophospholipids at m/z 772.5 (Panel A) and 774.5 (Panel B)
were performed by using an LTQ-Orbitrap mass spectrometer. Analyses were conducted using a peak width setting of 1 Th by selection of the
molecular ion in the linear ion trap (LTQ), collision activation in the C-trap with a normalized collision energy of 55% and gas pressure of 1 mTorr, and
analysis of the resultant product ions in the Orbitrap.
doi:10.1371/journal.pone.0001368.g003
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carboxylates also identified the presence of 17:1-22:6/22:6-17:1
dPtdEtn from the very low abundant isobaric ion at m/z 774.51
and the presence of 18:0-20:0/20:0-18:0 dPtdEtn from another
very low abundance isobaric ion at m/z 774.60 (Table 1).
The paired pPtdEtn molecular species present in bovine heart
PtdEtn mixtures were extensively examined through accurate
mass analyses of fragments resulting from CID of all acid-labile
PtdEtn ions (Table 1). The results demonstrated that pPtdEtn
molecular species were paired in most of the examined ions
corresponding to acid-labile peaks (i.e., pPtdEtn species) except a
number of very low abundant pPtdEtn molecular species (Table 1).
Collectively, a total 53 pairs of pPtdEtn molecular species were
identified from purified bovine heart PtdEtn while 26 pPtdEtn
molecular species were identified that had no obvious ion pairs
likely due to their extremely low abundance (Table 1).
Validation of the paired rule with synthetic lipids in
conjunction with acid or base treatment
To exclude the possibility that one of the paired pPtdEtn
molecular species which generates FA carboxylate (usually in
low or very low abundance after CID) was due to the presence of
an unknown fragmentation pathway of pPtdEtn molecular ions,
additional experiments on the analyses of synthetic pPtdEtn
molecular species were conducted. For example, tandem MS
analysis of 18:0-20:4 pPtdEtn after CID demonstrates an
abundant fragment ion at m/z 303.23 (i.e., 20:4 FA carboxylate),
a modest fragment ion at m/z 259.24 (corresponding to the
aliphatic anion resulting from the loss of a CO2 molecule from
arachidonate as mentioned above), two fragment ions at m/z
446.30 and 464.31 (i.e., lyso-pPtdEtn derivatives), and a very low
abundance ion at m/z 267.27 (corresponding to octadecan-19-
enolate which indicates that the pPtdEtn molecular species
containing 18:0 vinyl ether is the most abundant one in all
isomeric species) (Figure 4). No detectable fragment ion at m/z
283.26 (i.e., 18:0 FA carboxylate) was present in the mass
spectrum (Figure 4 inset). Identical results were also obtained from
the analyses of other synthetic plasmalogen molecular species (data
not shown). Accordingly, the very low abundance FA carboxylate
fragments present in the tandem MS analyses of pPtdEtn in bovine
heart PtdEtn did not result from an unknown CID pathway,
further supporting the presence of the paired pPtdEtn molecular
species in biological lipid extracts.
To further validate the paired rule for pPtdEtn molecular
species, we performed additional experiments to directly demon-
strate the presence of very long aliphatic chains containing high
degrees of unsaturation which are usually present in one of the
paired pPtdEtn molecular species with low to very low abundance
(Table 1). The bovine heart PtdEtn mixture was treated with 1 M
LiOMe to cleave the FA ester bonds of PtdEtn as previously
described [26]. The resultant solution was washed with 1:4 (v/v)
ethyl ether/hexane three times to remove the fatty acyl esters
generated by this procedure. The resultant lysoPtdEtn containing
an ether aliphatic chain at the sn-1 position of glycerol was
recovered by using a modified Bligh and Dyer extraction
procedure [21]. The ether lysoPtdEtn molecular species were
analyzed by ESI/MS in the negative-ion mode and the presence of
very long aliphatic chains containing high degrees of unsaturation
in low abundance (e.g., the ion at m/z 510.2) was detected
(Figure 5A). These low abundance ether lysoPtdEtn molecular
species were more clearly visualized after Fmoc chloride treatment
Figure 4. Product ion analyses of synthetic 18:0-20:4 plasmenylethanolamine molecular species in the negative-ion mode. Product ion ESI/MS
analysis of deprotonated 18:0-20:4 plasmenylethanolamine at m/z 750.54 was performed on an LTQ-Orbitrap mass spectrometer with a C-trap using
an ion selective window of 1 Th by LTQ. Collision activation in C-trap was carried out with normalized collision energy of 55% and gas pressure of
1 mT. The resultant fragment ions were analyzed in the Orbitrap. The arrow indicates the absence of the 18:0 FA carboxylate in the spectrum after
amplifying the position greater than1,000 fold.
doi:10.1371/journal.pone.0001368.g004
Lipidomics and Ether Lipids
PLoS ONE | www.plosone.org 9 December 2007 | Issue 12 | e1368(Figure 5B) as previously described [16], particularly in the mass
spectrum acquired by neutral loss of the Fmoc moiety (neutral loss
of 222.2 u) (Figure 5C). Quantitative analyses of these ether
lysoPtdEtn molecular species in comparison to an internal
standard after
13C deisotoping [18,27] corresponded well with
the aliphatic chain composition of the ether PtdEtn molecular
species listed in Table 1 (Figure 5D). These results support the
hypothesis that paired pPtdEtn isomers are present in lipid extracts
of biological samples.
To confirm that the major contents of these ether-containing
lysoPtdEtn molecular species contained vinyl ether linkages (and
not O-alkyl ether bonds (i.e., lyso-aPtdEtn)), lysoPtdEtn resulting
from alkaline hydrolysis treatment along with the internal standard
(which was added during the Bligh and Dyer extraction) were
further treated with acidic vapor to specifically cleave vinyl ether
bonds. The recovered lyso-aPtdEtn molecular species with the
lyso-dPtdEtn internal standard were analyzed by ESI/MS in the
negative-ion mode. The abundance of residual lyso-aPtdEtn
molecular species was not significantly above background relative
to the internal standard (spectrum not shown), indicating the low
abundance of aPtdEtn molecular species in bovine heart PtdEtn.
The quantitative results obtained from this approach agreed well
with the results obtained through accurate mass analyses (Table 1).
Shotgun lipidomics reveals the presence of paired
isomers of plasmalogen molecular species in a wide
variety of lipid extracts of biological samples from
multiple cell types and species
Next, we examined whether this paired rule was applicable to the
analysis of acid-labile, plasmalogen molecular species present in
lipid extracts from multiple mammalian tissues or extracellular
fluid samples including brain, heart, intestine, kidney, liver, and
dorsal root ganglia of rat, rabbit, mouse, and/or human. A
shotgun lipidomics approach was utilized to identify and quantify
lipid molecular species following intrasource separation as
described previously [18–20]. For example, PtdEtn molecular
species from mouse cerebellum were analyzed by survey scanning
in the negative-ion mode using an LTQ-Orbitrap mass spectrom-
eter after direct infusion of diluted lipid extract solutions
supplemented with a small amount LiOH (similar to Figure 6A).
Figure 5. Quantitative analyses of ether lysoPtdEtn produced by alkaline hydrolysis of fatty acyl esters in bovine heart PtdEtn. Bovine heart
PtdEtn solution was treated with LiOMe leading to the cleavage of the FA ester bonds in the PtdEtn pool as previously described [26]. The resultant
lysoPtdEtn mixture containing an ether aliphatic chain at the sn-1 position of glycerol was recovered using a modified procedure of Bligh and Dyer
[21]. The mass spectrum in panel A was acquired in the negative-ion mode by using a QqQ mass spectrometer directly from the lysoPtdEtn solution
that was diluted to less than 50 pmol of total lipids/ml. The mass spectrum in panel B was acquired in the negative-ion mode directly from a diluted
lysoPtdEtn solution after addition of Fmoc chloride as previously described [16]. The mass spectrum in panel C was acquired in the negative-ion
mode as that of spectrum B but in the neutral loss mode. The neutral loss scanning was conducted through coordinately scanning the first and third
quadrupoles with a mass difference of 222.2 u (i.e., loss of a Fmoc) while the collisional activation was performed in the second quadrupole at
collision energy of 32 eV. ‘‘IS’’ denotes internal standard. Panel D shows the comparison of ether aliphatic chain profiles in bovine heart PtdEtn
determined by using different approaches: (1) direct quantitation of the resultant ether lysoPtdEtn molecular species from alkaline hydrolysis of
PtdEtn (closed column) through a two-step quantitation procedure [5] from spectra A and C and (2) calculated composition (open column) derived
from individual PtdEtn molecular species listed in Table 1.
doi:10.1371/journal.pone.0001368.g005
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paired rule of pPtdEtn molecular species.
The results from the analyses of mouse cerebellar lipid extracts
were tabulated (Table 2) to include (1) all identified PtdEtn ions
shown in the survey scan with their determined accurate masses
(column 1), their corresponding formulas derived from their
accurate masses (column 2), and their contents which were
ratiometrically determined in comparison to the selected internal
standard after
13C de-isotoping [18,27] (column 3); (2) pPtdEtn
molecular species with or without their identified paired
counterparts (column 4); (3) aPtdEtn molecular species with or
without their identified paired counterparts (column 5); (4)
dPtdEtn molecular species identified (column 6); and (5) the
composition of FA carboxylates in each isobaric peak which
resulted from the fragmentation of each individual ion after CID
(in the parentheses under each PtdEtn molecular species of
columns 4–6). A total of 47 pairs of pPtdEtn molecular species in
mouse cerebellar lipid extracts were identified while 15 pPtdEtn
molecular species were also identified without pairing. These
pPtdEtn species are likely unpaired due to their extremely low
abundance (Table 2). The content of these 15 pPtdEtn molecular
species only accounts for 0.34 mol% of total ether PtdEtn content
or 0.16 mol% of total mouse cerebellar PtdEtn content (Table 2).
If a QqQ mass spectrometer instead of a high mass accuracy/
high resolution instrument was used to analyze the molecular ions
corresponding to PtdEtn molecular species in general and to
pPtdEtn molecular species in particular, three approaches were
employed. First, we analyzed the diluted lipid extracts using
negative-ion ESI/MS after treating the dried film of each lipid
solution with acidic vapor (Figure 6B). The mass spectrum clearly
shows the disappearance or substantial reductions in peak
intensities of many ions which correspond to pPtdEtn molecular
species (compare Figure 6B and 6A). The unchanged ion peaks
predominantly correspond to dPtdEtn molecular species, while the
Figure 6. Representative negative-ion ESI/MS analyses of individual ethanolamine glycerophospholipid molecular species in mouse cerebellar
lipid extracts. Mouse cerebellar lipid extracts were prepared by a modified Bligh and Dyer procedure [21]. Spectrum A was acquired in the negative-
ion mode by using a QqQ mass spectrometer directly from a lipid extract that was diluted to less than 50 pmol of total lipids/ml after addition of
approximately 25 pmol LiOH/ml to the lipid solution. Spectrum B was taken in the negative-ion mode after the diluted lipid solution used in spectrum
A was treated with acid vapor and a small amount of LiOH (approximately 25 pmol LiOH/ml) was added to the infused solution. Spectrum C was
acquired in the negative-ion mode as that of spectrum A but in the precursor-ion mode. The tandem mass spectrometry of precursor-ion scanning of
196 Th (i.e., phosphoethanolamine) was conducted through scanning the first quadrupole in the interested mass range and monitoring the third
quadruple with the ion at m/z 196 while collision activation was performed in the second quadrupole at collision energy of 50 eV. Spectrum D was
acquired in the negative-ion mode directly from a diluted mouse cerebellum lipid extract after addition of Fmoc chloride as previously described [16].
Spectrum E was acquired in the negative-ion mode as that of spectrum D but in the neutral loss mode. Tandem mass spectrometry of neutral loss
scanning was conducted through coordinately scanning the first and third quadrupoles with a mass difference of 222.2 u (i.e., loss of a Fmoc) while
collisional activation was performed in the second quadrupole at collision energy of 32 eV. ‘‘IS’’ denotes internal standard. All mass spectral traces are
displayed after normalization to the base peak in each individual spectrum. All spectra are displayed after being normalized to the base peak in
individual spectrum.
doi:10.1371/journal.pone.0001368.g006
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PLoS ONE | www.plosone.org 15 December 2007 | Issue 12 | e1368residual ion peaks are those of either isomeric aPtdEtn molecular
species or isobaric dPtdEtn (e.g., those containing a FA with an
odd-numbered carbons) to pPtdEtn molecular species. Next, we
profiled the diluted lipid extracts by using precursor-ion scanning
of 196 Th (i.e., phosphoethanolamine) to further confirm the
molecular ions corresponding to the pPtdEtn molecular species
since these ions were enhanced (Figure 6C) due to differential
fragmentation pathways as previously described [24]. Collectively,
from these measurements, molecular ions corresponding to
pPtdEtn and aPtdEtn were definitively identified (Table 2).
Finally, we employed a derivatization approach where the
PtdEtn molecular species were tagged by addition of Fmoc and
analyzed in the negative-ion mode (Figure 6D) as previously
described [5,16]. Neutral loss scanning of 222.2 u (corresponding
to the Fmoc moiety) (Figure 6E) allowed us (1) to definitively
identify the PtdEtn molecular ions in the mass spectrum presented
in Figure 6A; (2) to eliminate overlap of PtdEtn molecular species
with other molecular species from different lipid classes as
determined by shotgun lipidomics; and (3) to detect the presence
of very low-abundance PtdEtn molecular species. Therefore, all
molecular ions corresponding to PtdEtn were determined and
tabulated (Table 2). The ether aliphatic and acyl chain identities of
these identified PtdEtn molecular species were similarly deter-
mined by multi-dimensional MS analyses of Fmoc-PtdEtn using a
QqQ mass spectrometer as previously described [18–20].
Identification of plasmalogen molecular species in
combination with the paired rule facilitates the
identification of alkyl-acyl phospholipid molecular
species by shotgun lipidomics
It is well known that the biosynthesis of pPtdEtn molecular species
occurs through their alkyl-acyl phospholipid precursors (i.e.,
aPtdEtn) which undergo C-1 desaturation of the alkyl chain by
a desaturase activity in the endoplasmic reticulum [1]. Notably,
the content of pPtdEtn molecular species in almost all mammalian
tissues are considerably higher (.10 times in most cases) than
those of their aPtdEtn precursors [2,6]. Therefore, the identified
paired rule for pPtdEtn molecular species is also valid for the
aPtdEtn subclass of phospholipids. Moreover, since the levels of
pPtdEtn molecular species in mammalian samples are always
much higher than those of their corresponding aPtdEtn precur-
sors, the identified pPtdEtn molecular species and their abundance
facilitate identification of the corresponding aPtdEtn.
For example, the ion at m/z 772.5 contained a 20:4 carboxylate
as determined by CID analysis of bovine heart PtdEtn (Figure 3A)
leading to the identification of 20:4-20:4 aPtdEtn. Since
plasmalogens were present at this m/z along with the 20:4
carboxylate, the presence of 20:4-20:4 aPtdEtn was inferred. This
identification was substantiated by the presence of a pair of 20:4-
20:4/20:4-20:4 pPtdEtn molecular species at m/z 770.51 (Table 1)
of which the 20:4-20:4/20:4-20:4 aPtdEtn served as the metabolic
precursor. Since the abundance of an aPtdEtn precursor was
approximately 10 mol% or less than that of its corresponding
pPtdEtn counterpart, it was anticipated that the observed 20:4 FA
carboxylate could also result from a 20:3-20:4 pPtdEtn species or
its isomer, 20:4-20:3 pPtdEtn. However, the 20:3 FA carboxylate
could not be detected likely due to its extremely low abundance
beyond the limits of detection using the current technology.
Similarly, the presence of the paired 18:1-22:6/22:6-18:1 and
18:2-22:5/22:5-18:2 and an unpaired 20:3-20:4 pPtdEtn molec-
ular species at m/z 772.53 facilitated the identification of the
paired 18:1-22:6/22:6-18:1 and 18:2-22:5/22:5-18:2 and an
unpaired 20:3-20:4 aPtdEtn molecular species at m/z 774.54 as
it would be obligatory that the metabolic precursor be present
(Table 1). It was found that the majority of relatively abundant
aPtdEtn molecular species present in mouse cerebellar extracts were
paired(25pairs),leading tothe predictionthatotherpairsofaPtdEtn
molecular species were also likely present, but below the level of
detectability due to their extremely low abundance (Table 2).
Differential profiles of ether lipid aliphatic chains
are present in comparison to non-ether lipid fatty
acyl chains representative of subclass specific
enzymatic selectivity during biosynthesis/
remodeling
To further uncover the abundant, but cryptic, biochemical
information present in the acyl chain composition of cellular lipids,
the obligatory diversity in aliphatic chain regiospecificity predicted
by the paired rule in different phospholipid molecular species was
exploited. The composition of O-alkyl or O-alkenyl (sn-1) chains in
ether PtdEtn molecular species present in bovine heart lipid extracts
demonstrated that 16:0 (31.1 mol%), 18:0 (34.6 mol%), and 18:1
(22.7 mol%) moieties were predominant with smaller amounts of
17:0, 18:2, 16:1, 19:0, and 14:0 chains (in order of decreasing
abundance). Other less abundant aliphatic chains collectively
accounted for only 0.5 mol% of the total bovine heart ether PtdEtn.
This molecular species profile wasvery different from that of the acyl
CoA pool in bovine heart (Figure 7C). This difference clearly
indicates the selective activities of the acyl-CoA reductase and the
alkyl DHAP synthase which are involved in the synthesis of the
obligatory precursor of ether lipids, alkyl DHAP (Figure 8).
Analyses of the fatty acyl chains derived from ether PtdEtn
molecular species present in bovine heart showed a very different
profile from that of either the fatty aliphatic chains of ether PtdEtn
(Figure 7A) or fatty acyl-CoAs determined from the same organ
[28] (Figure 7C). The fatty acyl chains of bovine heart ether
PtdEtn were predominantly 18:2 FA (46.9 mol%) and 20:4 FA
(32.6 mol%) with lesser amounts of 22:5, 20:3, 20:5, 22:4, and
18:3 FA (8.5, 4.2, 3.9, 2.1, and 0.9 mol%, respectively). The
remainder of sn-2 FA chains accounted for approximately
0.9 mol% of the total fatty acyl chains in ether PtdEtn. In contrast
to the predominantly 16 or 18 carbon saturated or monounsat-
urated fatty aliphatic chains present at the sn-1 position of ether
PtdEtn, those occupying the sn-2 position were essentially all
polyunsaturated and the majority contained 20 or 22 carbons
(Figure 7A). This fatty acyl chain profile resulted from either a
selective acyl-CoA acyltransferase activity or subsequent remod-
eling or both (Figure 8).
Lipidomics at its current stage is unable to accurately
discriminate the sn-1 and sn-2 acyl moieties present in diacyl
phospholipid species, although approximate assessments of
regiospecificity can be obtained from the ratios of fragment ions
as previously described [24]. We summarized the overall
composition of FA chains in the dPtdEtn subclass of bovine heart
PtdEtn without determination of their regiospecific positions
(Figure 7B). Analyses of these dPtdEtn-derived FA chains
demonstrated a very different profile (Figure 7B) from either that
of ether PtdEtn aliphatic/acyl chains (Figure 7A) or fatty acyl-
CoAs in bovine heart (Figure 7C). The FA chains of dPtdEtn in
bovine heart were predominantly 18:0 FA (42.9 mol%) and 20:4
FA (34.9 mol%) followed by 18:2, 18:1, 20:5, 22:5, 16:0, and 17:0
FA (11.4, 3.8, 2.6, 2.3, 0.8, and 0.4 mol%, respectively). The
remainder accounted for 0.9 mol% of the total FA chains in
bovine heart dPtdEtn. Like the FA chain profile of ether PtdEtn,
this profile of FA chains derived from dPtdEtn resulted from either
Lipidomics and Ether Lipids
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remodeling or both (Figure 8). Although it is conceivable that
the majority of the saturated FA chains were present at sn-1
whereas polyunsaturated FA chains were located at sn-2 of
dPtdEtn, such a distribution is considerably different from those of
ether PtdEtn (compare Figure 7B to Figure 7A).
DISCUSSION
The current study utilizes high mass accuracy/high resolution
mass spectrometry (i.e., an LTQ-Orbitrap mass spectrometer) in
conjunction with tandem mass spectrometry to greatly extend the
quantitative and qualitative analyses of the ether lipid-containing
lipidome in multiple organs and species. Through utilization of
synthetic reagents, chemical covalent modification, and accurate
mass determinations, we identified ‘‘the paired rule’’ of ether-
containing phospholipid molecular species. This rule states that
any individual ether-containing PtdEtn molecular species A9-B
(where the 9 indicates the vinyl ether linkage of the aliphatic chain
Aa tsn-1 and B denotes the sn-2 acyl chain) is necessarily paired
with a corresponding isomer B9-A (where B9 is the vinyl ether
linkage and A is the ester) (Figure 1). The biochemical basis
underlying this rule is the lack of absolute specificity in the
Figure 7. Comparison of representative aliphatic or acyl chain profiles in different lipid domains of bovine heart. The profiles of both aliphatic
chains (open column in Panel A) and fatty acyl chains (closed column in Panel A) of bovine heart ether-linked ethanolamine glycerophospholipids
(PtdEtn) were derived from individual molecular species listed in Table 1. The fatty acyl chain composition of bovine heart diacyl PtdEtn (Panel B) was
also calculated from the identified individual molecular species as listed in Table 1. The profile of acyl-CoA in bovine heart (Panel C) was re-plotted
from previously published data [28].
doi:10.1371/journal.pone.0001368.g007
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PtdEtn molecular species, resulting in the presence of varying
amounts of the corresponding isomers depending on the relative
specificity of the involved synthetic enzymes for an individual FA
chain. Accordingly, this study predicts and demonstrates an inter-
relationship between corresponding sets (A9-B and B9-A) of ether-
containing phospholipid molecular species, greatly increases the
number of known ether-containing phospholipid molecular species
present and predicts the structural composition of additional ether
lipid molecular species in the extremely low abundance regime.
The origination of this paired rule of ether-containing
phospholipid molecular species is embedded in the biosynthetic
pathway of lipids where a common substrate pool, i.e., acyl-CoA is
used in multiple steps as a source of both fatty aliphatic and FA
chains used in the synthesis of these phospholipids (Figure 8).
Specifically, acyl-CoA is utilized by DHAP acyltransferase to
synthesize the phospholipid (both diacyl and ether linked)
precursor acyl DHAP in the presence of DHAP. This common
pool of acyl-CoA also serves as a source of fatty alcohol through
reduction mediated by NADPH-acyl-CoA reductase [1,2]. These
fatty alcohol species react with acyl DHAP through catalysis by
alkyl DHAP synthase to generate alkyl DHAP which is further
reduced by an alkyl DHAP reductase activity to yield 1-O-alkyl-
glycero-3-phosphate. Acylation of 1-O-alkyl-glycero-3-phosphate
with acyl-CoA results in alkyl-acyl glycerophosphate which leads
to the final syntheses of aPtdEtn and aPtdCho, both of which are
desaturated to yield pPtdEtn and pPtdCho. In theory, if any of the
enzymatic activities of acyl-CoA reductase, alkyl DHAP synthase,
alkyl DHAP reductase, and acyl-CoA/1-O-alkyl-glycero-3-phos-
phate acyltransferase as mentioned above is completely selective to
certain fatty acyl-CoA or fatty alcohol molecular species (Figure 8)
[1,2], the final ether-containing phospholipid molecular species
should be limited to specific aliphatic/acyl chains. However, the
results of this study indicate that although ether aliphatic chains in
PtdEtn pool were restricted to largely 16:0, 18:0, and 18:1 species,
much lower abundant molecular species corresponding to those
predicted by the paired rule were routinely observed. It should also
be pointed out that the pairing distributions are a complex
function of diet, substrate availability, intracellular organelle
compartmentation, and substrate-enzyme interactions at the active
site. Furthermore, it is anticipated that the paired rule is also valid
for ether PtdCho molecular species since they are generated from
an identical pool of precursors, i.e., alkyl-acyl glycerophosphate.
The identification of ‘‘the paired rule’’ for ether-containing
species implies that other corollaries of this rule exist in lipid
biology. First, although the paired rule has been validated through
identification of ‘‘matched sets’’ of ether-containing phospholipids,
the limited regiospecificity of intracellular phospholipases renders
it likely that additional pairing is present in diacyl phospholipid
pools. This is further substantiated by the known isomerization of
alpha hydroxyl alcohols which likely occur in vivo. Since the
physical properties of a given pair of A-B and B-A diacyl
phospholipids are separate and distinct, we speculate that such
pairing may facilitate the appropriate molecular dynamics and
development of specific molecular scaffolds within membranes.
However, absolute proof of this hypothesis awaits the development
of new lipidomic techniques to provide absolute discrimination of
sn-1 vs. sn-2 regiospecificity.
The results of this study are the first to directly demonstrate the
existence of large numbers of ether lipids present in a cellular
lipidome at the limits of detectability using current lipidomic
technology. Due to the limited selectivity and/or specificity of
enzymes that are involved in lipid biosynthesis and remodeling, all
available acyl-CoA molecular species can be incorporated into a
given lipid class to some degree. Thus, the numbers of lipid
molecular species present in a cellular lipidome are now
recognized to be a function of detectability with their isomeric
counterparts implied and/or observed in high sensitivity analyses.
Furthermore, the present results establishing the paired rule of
ether-containing phospholipids will greatly aid identification of the
moieties in cellular lipidomes through specifically targeting
predicted molecular species during mass spectrometric analyses.
This rule has defined criteria for the identification of individual
molecular species of both plasmalogen and plasmanyl subclasses
and for discrimination between plasmalogen and alkyl-acyl
isomers. For example, in theory, the aPtdEtn precursor of each
identified pPtdEtn molecular species should exist in the lipid
extracts of the samples. These and other similar conceptualizations
will advance lipidomics analyses to identify a new level of
potentially valuable biomarkers. Although some predictable
Figure 8. Pathways involved in the biosynthesis of plasmenylethanolamine. The enzymes that may be involved in non-selective utilization of acyl
CoA pool are highlighted with broken-lined frames. ** CDP-ethanolamine: 1-O-alkyl-2-acyl-sn-glycerol ethanolamine phosphotransferase.
doi:10.1371/journal.pone.0001368.g008
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PLoS ONE | www.plosone.org 18 December 2007 | Issue 12 | e1368limitations due to the current technology are still present, it is clear
that as the sensitivity of mass spectrometers increases these
moieties will provide independent biomarkers which reflect a wide
variety of turnover rates within cells. The power of this newly-
identified paired rule of ether-containing phospholipid molecular
species will greatly aid identification of extremely low abundance
molecular species and provide new biomarkers of health and
disease.
Finally, through the perspective of the paired rule, the
selectivities and/or activities of enzymes that are involved in
plasmalogen and plasmanyl phospholipid biosynthesis and/or
remodeling during different pathophysiological states in an intact
cell can be determined. Unlike previous studies in which only a
limited number of abundant ether-containing phospholipids could
be quantified, profiling plasmalogen and plasmanyl molecular
species on a large scale as proposed herein (i.e., through exploiting
high mass accuracy/resolution mass spectrometry) should dra-
matically enhance multiparametric assessments of the disease
states of interest or their response to therapy.
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